Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Robertson

Showing results (841-850 of 1,169) with videos related to

Pageof 117
Sort By:
The Journal of Trauma|December 1, 1990
Delayed, exsanguinating pelvic hemorrhage after blunt trauma without bony fracture: case reportF Baumgartner, G H White, R A White, et al.
Paediatric and Perinatal Epidemiology|April 1, 1997
A cohort study of pregnancy outcome after amniocentesis in twin pregnancyS A Kidd, P A Lancaster, J C Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virusJ W Wilkins, K R Robertson, C van der Horst, et al.
Clinical Breast Cancer|December 3, 2014
A good drug made better: the fulvestrant dose-response storyJohn F R Robertson, Justin Lindemann, Sally Garnett, et al.
Clinical Trials (London, England)|August 24, 2022
Importance of patient engagement in the conduct of pragmatic multicenter randomized controlled trials: The ADAPTABLE experienceGuillaume Marquis-Gravel, Madelaine Faulkner, Greg Merritt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.
Chemistryopen|January 11, 2018
Extending the Scope of <sup>19</sup>F Hyperpolarization through Signal Amplification by Reversible Exchange in MRI and NMR SpectroscopyAlexandra M Olaru, Thomas B R Robertson, Jennifer S Lewis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2007
Assessing health-related quality of life in NeuroAIDS: some psychometric properties of the Neurological Quality of Life Questionnaire (NeuroQOL)Kevin R Robertson, Thomas D Parsons, Steven A Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST studyJohn F R Robertson, Antonio Llombart-Cussac, Janusz Rolski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experienceM Hudson, M R Jaffe, N Jaffe, et al.
Pageof 117

Showing results (841-850 of 1,169) with videos related to

Sort By:
Pageof 117
The Journal of Trauma|December 1, 1990
Delayed, exsanguinating pelvic hemorrhage after blunt trauma without bony fracture: case reportF Baumgartner, G H White, R A White, et al.
Paediatric and Perinatal Epidemiology|April 1, 1997
A cohort study of pregnancy outcome after amniocentesis in twin pregnancyS A Kidd, P A Lancaster, J C Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virusJ W Wilkins, K R Robertson, C van der Horst, et al.
Clinical Breast Cancer|December 3, 2014
A good drug made better: the fulvestrant dose-response storyJohn F R Robertson, Justin Lindemann, Sally Garnett, et al.
Clinical Trials (London, England)|August 24, 2022
Importance of patient engagement in the conduct of pragmatic multicenter randomized controlled trials: The ADAPTABLE experienceGuillaume Marquis-Gravel, Madelaine Faulkner, Greg Merritt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.
Chemistryopen|January 11, 2018
Extending the Scope of <sup>19</sup>F Hyperpolarization through Signal Amplification by Reversible Exchange in MRI and NMR SpectroscopyAlexandra M Olaru, Thomas B R Robertson, Jennifer S Lewis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2007
Assessing health-related quality of life in NeuroAIDS: some psychometric properties of the Neurological Quality of Life Questionnaire (NeuroQOL)Kevin R Robertson, Thomas D Parsons, Steven A Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST studyJohn F R Robertson, Antonio Llombart-Cussac, Janusz Rolski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experienceM Hudson, M R Jaffe, N Jaffe, et al.
Pageof 117